U.S. scientists have identified a potential target for a vaccine to fight Chlamydia -- the world's most prevalent sexually transmitted bacterial infection.
Researchers at the University of Pittsburgh Medical Center's Children's Hospital, led by Dr. Toni Darville, identified a plasmid-deficient strain of Chlamydia trachomatis that, when investigated in an animal model of genital tract infection, failed to cause disease. Plasmids are small molecules of DNA.
"This finding represents a major step forward in our work to eventually develop a vaccine against chlamydial disease," said Darville, a professor of pediatrics and microbiology/immunology. "If we can identify plasmid-deficient derivatives of the C. trachomatis strains that infect humans, they would have the potential to serve as a vaccine against this disease."
The study is reported in the Journal of Immunology.
Copyright 2007 by United Press International
Related stories:
Vaccine for koala chlamydia close
Professors Peter Timms and Ken Beagley from Queensland University of Technology's Institute of Health and Biomedical Innovation (IHBI) said the vaccinated koalas, which are at Brisbane's Lone Pine Koala Sanctuary, were mounting a good response to the vaccine.
'Good bacteria' in women give clues for slowing HIV transmission
Beneficial bacteria found in healthy women help to reduce the amount of vaginal HIV among HIV-infected women and make it more difficult for the virus to spread, boosting the possibility that “good bacteria” might someday be tapped in the fight against HIV.
Multiple species of bacteria may cause trachoma: Implications for treatment
In a study published in this week’s PLoS Medicine, researchers have found that more than one species of bacteria may be causing the infectious eye disease trachoma. Six million people – most of whom live in crowded and unhygienic conditions in the developing world – are blind because of the disease and many more are actively infected. The possibility that multiple strains of the Chlamydiceae family of bacteria are involved in trachoma would involve a re-evaluation of vaccines and treatment programmes.
Mice help researchers understand chlamydia
Genetically engineered mice may hold the key to helping scientists from Queensland University of Technology and Harvard hasten the development of a vaccine to protect adolescent girls against the most common sexually transmitted disease, Chlamydia.
Koala Chlamydia vaccine to be tested
The first trials of an Australian vaccine designed to protect koalas from Chlamydia infection is being planned.
Vaccine trials inject hope into koala's future
The first Australian trials of a vaccine developed by Queensland University of Technology that could save Australia's iconic koala from contracting chlamydia are planned to begin later this year.
Chlamydia vaccine a step closer to reality
Scientists at Queensland University of Technology are one step closer to developing a world-first vaccine to protect women against contracting the most common sexually-transmitted disease, Chlamydia.
Scientists work toward a Chlamydia vaccine
U.S. scientists studying how the immune system responds to genital tract infections are using a mouse model to track immunity against Chlamydia.